Efficacy evaluation of deep throat saliva test in diagnosis of pulmonary tuberculosis using GeneXpert MTB/RIF Ultra

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043733

Enrollment

Unknown

Registered

2021-02-27

Start date

2021-03-15

Completion date

Unknown

Last updated

2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Gold Standard:MGIT 960 Culture

Index test:GeneXpert&#32

MTB/RIF&#32

Ultra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Suspected pulmonary tuberculosis patients in Hospital; 2. Patients who have no sputum or can not provide qualified sputum samples; 3. Volunteers who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who can't cooperate with the collection of specimens; 2. Patients who can't tolerate bronchoscopy and have contraindications of bronchoscopy.

Design outcomes

Primary

Measure	Time frame
sensitivity;Specificity;	—

Countries

China

Contacts

Public ContactPeijun Tang

The Fifth People's Hospital of Suzhou

tangpeipei001@163.com+86 13773035577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026